Revvity | PKI - Fremdkapital





Fremdkapital Veränderung Datum
Agilent USD 3.05B 1000K 2026-03
Align Technology USD 0 0 2024-12
Bio Techne USD 200M 60M 2026-03
Bio-Rad Laboratories USD 803M 100K 2026-06
Bruker USD 1.81B 151.8M 2026-06
Celltrion KRW 411.27B 998.23M 2026-03
Charles River Laboratories USD 2.62B 43.15M 2026-06
Cspc Pharmaceutical CNY 180.69M 21.94M 2025-12
Danaher USD 25.15B 7.59B 2026-06
Dentsply International USD 2B 10M 2026-06
Deva Holding AS TRY 559.97M 44.39M 2023-09
Dianthus Therapeutics USD 0 0 2024-12
Divis Laboratories Ltd INR 50M 30M 2026-03
Edwards Lifesciences USD 598.7M 1.3M 2026-06
Illumina USD 1.49B 1000K 2026-06
Intuitive Surgical USD 0 0 2025-03
IQVIA Holdings USD 13.7B 284M 2026-06
Kangmei Pharma CNY 68.57M 9.87M 2026-03
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Laboratorios Farma EUR 80.5M 28.26M 2024-12
Laboratory Of America USD 5.92B 23.3M 2026-06
Malin Corporation EUR 0 0 2024-12
Medical Developments International AUD 1.5M 167K 2025-12
Mesa Laboratories USD 104.2M 104.3M 2024-09
Mettler Toledo International USD 2.04B 116.92M 2026-06
Myriad Genetics USD 120.7M 400K 2026-06
OraSure Technologies USD 100K 17K 2025-12
Organigram Holdings CAD 60.76M 1.77M 2026-03
Ovoca Bio EUR 0 0 2021-06
Pacific Biosciences Of California USD 645.38M 223K 2025-12
Pharma Mar EUR 32.13M 1.04M 2026-06
Qiagen NV USD 1.63B 19.45M 2026-06
Quest Diagnostics USD 5.63B 477M 2026-06
Quidel USD 2.54B 2.54B 2026-06
Repligen USD 551.05M 4.46M 2026-06
Revvity USD 2.63B 1.02M 2026-06
Sartorius EUR 3.65B 311.1M 2026-06
Sino Biopharmaceutical CNY 3.08B 1B 2025-06
Thermo Fisher Scientific USD 39.18B 890M 2026-06
Tilray USD 268.59M 3.82M 2025-09
Waters USD 5.09B 129M 2026-06
Zealand Pharma A/S 307M 76.14M 2026-03
Zz Pientze Pharmaceu CNY 182.29M 4.27M 2026-03